Picture of Oncolys Biopharma logo

4588 — Oncolys Biopharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Table: Oncolys Biopharma -2020 parent results

Feb 12 (Reuters)- 
          Oncolys Biopharma Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended       Year to       NEXT   
               Dec 31, 2020    Dec 31, 2019   Dec 31, 2021     YEAR     
                  LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS       FORECAST    H1 FORECAST 
  Sales          314 mln           1.30                                 
               (-75.9 pct)     (+673.5 pct)                             
  Operating     loss 1.67      loss 511 mln                             
  Recurring     loss 1.72      loss 539 mln                             
  Net           loss 2.10      loss 912 mln                             
  EPS        loss 145.58 yen  loss 65.55 yen                            
  Ann Div          NIL              NIL            NIL                  
  -Q2 Div          NIL              NIL            NIL                  
  -Q4 Div          NIL              NIL            NIL                  
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T

Recent news on Oncolys Biopharma

See all news